SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased Fulcrum Therapeutics, Inc. (NASDAQ: FULC) common ...
NEW YORK, NY / ACCESSWIRE / May 17, 2023 / FULCRUM THERAPEUTICS, INC. (NASDAQ:FULC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff ...
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased Fulcrum Therapeutics, Inc.
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulcrum Therapeutics Inc., (NASDAQ: FULC) between March 3, 2022 and March 8, 2023 ...
Did you lose money on investments in Fulcrum Therapeutics, Inc.? If so, please visit Fulcrum Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or ...
NEW YORK, NY / ACCESSWIRE / May 15, 2023 / Pomerantz LLP announces that a class action lawsuit has been filed against Fulcrum Therapeutics, Inc. ("Fulcrum" or the "Company") (NASDAQ:FULC), and certain ...
Did you lose money on investments in Fulcrum Therapeutics, Inc.? If so, please visitFulcrum Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results